MAPT and Alzheimer disease: Elevated levels of pathological proteins such as phosphorylated tau (pS396, pT181, pT231) and amyloid‐beta (Aβ1–42) have been consistently identified in AD‐derived EVs (Muraoka, Jedrychowski, et al. 2020).